ChiCTR2200055289 版本V1.1 版本创建时间2022/08/03 17:48:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200055289 

最近更新日期:

Date of Last Refreshed on:

2022-01-05 15:57:32 

注册时间:

Date of Registration:

2022-01-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

髂腰肌平面阻滞对髋部手术患者术后恢复质量的影响

Public title:

Effect of Iliopsoas Plane Block on Postoperative Recovery for patients underwent hip surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

髂腰肌平面阻滞对髋部手术患者术后恢复质量的影响

Scientific title:

Effect of Iliopsoas Plane Block on Postoperative Recovery for patients underwent hip surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王春光 

研究负责人:

王春光 

Applicant:

Chunguang Wang 

Study leader:

Chunguang Wang 

申请注册联系人电话:

Applicant telephone:

+86-18617789771

研究负责人电话:

Study leader's
telephone:

+86-18617789771

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangchunguang@163.com

研究负责人电子邮件:

Study leader's E-mail:

wangchunguang@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河北省保定市长城北大街320号保定市第一中心医院麻醉科

研究负责人通讯地址:

河北省保定市长城北大街320号保定市第一中心医院麻醉科

Applicant address:

Department of Anesthesiology, The First Central Hospital Of Baoding, Northern Greatwall Street 320# , Baoding, Hebei, 071000, China

Study leader's address:

Department of Anesthesiology, The First Central Hospital Of Baoding, Northern Greatwall Street 320# , Baoding, Hebei, 071000, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

保定市第一中心医院

Applicant's institution:

The First Central Hospital Of Baoding

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2021]181

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

保定市第一中心医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the First Central Hospital of Baoding

伦理委员会批准日期:

Date of approved by ethic committee:

2021-12-31 00:00:00

伦理委员会联系人:

宋雨轩

Contact Name of the ethic committee:

Yuxuan Song

伦理委员会联系地址:

河北省保定市长城北大街320号保定市第一中心医院

Contact Address of the ethic committee:

The First Central Hospital Of Baoding, Northern Greatwall Street 320# , Baoding, Hebei, 071000

伦理委员会联系人电话:

Contact phone of the ethic committee:

0312-5976906

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

保定市第一中心医院

Primary sponsor:

The First Central Hospital Of Baoding

研究实施负责(组长)单位地址:

河北省保定市长城北大街320号保定市第一中心医院

Primary sponsor's address:

The First Central Hospital Of Baoding, Northern Greatwall Street 320# , Baoding, Hebei, 071000

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河北

市(区县):

保定

Country:

China

Province:

Hebei

City:

Baoding

单位(医院):

保定市第一中心医院

具体地址:

长城北大街320号

Institution
hospital:

Baoding First Central Hospital

Address:

320 Changcheng Avenue North

经费或物资来源:

保定市第一中心医院

Source(s) of funding:

The First Central Hospital Of Baoding

研究疾病:

神经阻滞  

Target disease:

nerve block

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

观察髂腰肌平面阻滞对髋部手术患者术后恢复质量的影响  

Objectives of Study:

To observe the effect of Iliopsoas Plane Block on Postoperative Recovery for patients underwent hip surgery.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)因股骨颈骨折、髋关节重度骨关节炎、股骨头坏死、发育性髋关节发育不良继发骨关节炎,需行初次髋部手术的患者; (2)年龄大于18岁; (3)术前美国麻醉学家学会(American Society of Anesthesiologists,ASA)分级(麻醉风险评估)为Ⅰ ~ Ⅲ级。

Inclusion criteria

1. Patients scheduled for hip surgery due to femoral neck fracture, severe hip osteoarthritis, femoral head necrosis, and secondary osteoarthritis due to developmental hip dysplasia; 2. Aged 18 years and older; 3. Patients with preoperative American Society of anesthesiologists (ASA) grading of I ~ III.

排除标准:

(1)对试验中使用药物过敏者; (2)语言障碍及不能完成各种问卷评分者; (3)手术侧肢体神经病变者; (4)精神病患者;(5)严重骨质疏松; (6)有髋关节手术史; (7)病因为髋关节感染治愈后继发骨关节炎; (8)髂骨翼宽大或者髋臼后壁骨缺损的患者; (9)同期行其他手术者;(10)酗酒或长期服用阿片类等镇痛药物者; (11)既往存在消化道溃疡者。

Exclusion criteria:

1. Patients who are allergic to the drugs used in the experiment; 2. Patients with language disorders and inability to complete various questionnaire scores; 3. Patients with limb neuropathy on the operative side; 4. With mentally ill; 5. With severe osteoporosis; 6. With a history of hip surgery prior to the initial replacement; 7. Patients with secondary osteoarthritis after treatment of hip infection; 8. Patients with iliac wing width or acetabulum posterior wall bone defect;
9. Other operations were performed at the same stage; 10. Alcoholic or long-term opioid users; 11. Patients with previous gastrointestinal ulcer.

研究实施时间:

Study execute time:

From 2022-01-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-01-01 00:00:00 To 2023-12-31 00:00:00

干预措施:

Interventions:

组别:

A组

样本量:

50

Group:

Group A

Sample size:

干预措施:

髂腰肌平面阻滞

干预措施代码:

Intervention:

Iliopsoas plane block

Intervention code:

组别:

B组

样本量:

50

Group:

Group B

Sample size:

干预措施:

股神经阻滞

干预措施代码:

Intervention:

Femoral nerve block

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河北 

市(区县):

保定 

Country:

China

Province:

Hebei

City:

Baoding

单位(医院):

保定市第一中心医院 

单位级别:

三甲 

Institution
hospital:

The First Central Hospital of Baoding

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后恢复质量

指标类型:

主要指标

Outcome:

Postoperative quality of recovery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视觉模拟评分法疼痛评分

指标类型:

次要指标

Outcome:

Visual analogue scale pain score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

股四头肌肌力

指标类型:

次要指标

Outcome:

Quadriceps strength

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

阿片类药物用量

指标类型:

次要指标

Outcome:

Opioids consumption

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

髋关节活动度

指标类型:

次要指标

Outcome:

Range of motion

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

首次下床时间

指标类型:

次要指标

Outcome:

First time out of bed

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院时间

指标类型:

次要指标

Outcome:

Length of stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者满意度

指标类型:

次要指标

Outcome:

Patient satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后并发症发生率

指标类型:

次要指标

Outcome:

Incidence of postoperative complications

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Null

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

试验参与者使用计算机生成的随机数字列表,将患者随机分为两组

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients are randomly divided into two equal groups using a computer-generated list of random numbers by a participant.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

论文发表后即公开原始数据。试验的原始数据上传至中国临床试验注册中心的ResMan原始数据共享平台(IPD共享平台),http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The original data will be made public once the paper is published.The original data of the trial will be uploaded to the ResMan, http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

同时采用病历记录表和电子管理系统进行数据管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form and Electronic Data Capture are used for data management simultaneously

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-01-05 15:57:27